Derek Rapp - The Rivervest Cohort - Investing in Life Science Startups
Derek Rapp from Rivervest Venture Partners talks about investing in Life Sciences startups Rivervest Venture Partners' Startup Investment Strategy Mary Scott from BusinessRiff welcomed Derek Rapp from Rivervest Venture Partners for a discussion on startup investments. Derek explained that Rivervest, founded in 2000, specializes in investing in early-stage bio-pharmaceutical and medical device companies. They typically lead the first major institutional equity round and aim to help these companies reach their potential through follow-on investments until an eventual exit. Focusing on Life Sciences for Innovation Mary and Derek discussed the focus on life sciences over other technology sectors, highlighting the potential for products to address unmet patient needs and the enduring demand for healthier, longer lives. Derek mentioned the role of entrepreneurs and researchers in developing innovative solutions, such as artificial intelligence, devices to support cardiologists and surgeons, and advances in cancer and immunology research. He also noted the long-term potential of successful products to attract acquisition or public offering.